Marizyme, Inc. (MRZM)
OTCMKTS: MRZM · Delayed Price · USD
0.0533
-0.0008 (-1.48%)
Jun 20, 2024, 12:00 AM EDT - Market closed
Marizyme Market Cap
Marizyme has a market cap or net worth of $7.02 million as of July 3, 2024. Its market cap has decreased by -41.91% in one year.
Market Cap
7.02M
Enterprise Value
30.58M
1-Year Change
-41.91%
Ranking
n/a
Category
Stock Price
$0.05
Market Cap Chart
Since July 5, 2019, Marizyme's market cap has decreased from $20.06M to $7.02M, a decrease of -64.98%. That is a compound annual growth rate of -19.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 20, 2024 | 7.13M | 55.63% |
| Dec 29, 2023 | 4.58M | -78.72% |
| Dec 30, 2022 | 21.53M | -70.06% |
| Dec 31, 2021 | 71.91M | -19.94% |
| Dec 31, 2020 | 89.82M | 768.56% |
| Dec 31, 2019 | 10.34M | -48.44% |
View and export this data all the way back to 2019.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 869.02B |
| Novo Nordisk | 643.34B |
| UnitedHealth Group | 455.27B |
| Johnson & Johnson | 352.43B |
| Merck & Co. | 323.95B |
| AbbVie | 300.85B |
| AstraZeneca | 241.65B |
| Novartis AG | 208.44B |